Synergic activity of fluoroquinolones and linezolid against Mycobacterium tuberculosis
- 30 April 2003
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 21 (4) , 354-356
- https://doi.org/10.1016/s0924-8579(02)00387-4
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Global Trends in Resistance to Antituberculosis DrugsNew England Journal of Medicine, 2001
- In vitro activity of four fluoroquinolones against Mycobacterium tuberculosisInternational Journal of Antimicrobial Agents, 2001
- Activities of Several Novel Oxazolidinones against Mycobacterium tuberculosis in a Murine ModelAntimicrobial Agents and Chemotherapy, 1999
- Fluoroquinolone Action against Clinical Isolates of Mycobacterium tuberculosis : Effects of a C-8 Methoxyl Group on Survival in Liquid Media and in Human MacrophagesAntimicrobial Agents and Chemotherapy, 1999
- Acquired Drug Resistance inMycobacterium tuberculosisIsolates Recovered from Compliant Patients with Human Immunodeficiency Virus–Associated TuberculosisClinical Infectious Diseases, 1997
- Synergistic antimycobacterial activity between ethambutol and the beta-lactam drug cefepimeDiagnostic Microbiology and Infectious Disease, 1997
- Antimicrobial agent resistance in mycobacteria: molecular genetic insightsClinical Microbiology Reviews, 1995
- Characterization of fluoroquinolone-resistant mutant strains of Mycobacterium tuberculosis selected in the laboratory and isolated from patientsAntimicrobial Agents and Chemotherapy, 1995
- Clinically Significant Drug Interactions with Antituberculosis AgentsDrug Safety, 1994
- Synergic activity of teicoplanin and ethambutol against Mycobacterium tuberculosisJournal of Antimicrobial Chemotherapy, 1994